Senti Biosciences is a developer of a programmable biology platform for cancer therapies. Founded by Jim Collins, Philip Lee, Tim Lu,, Wilson Wong in 2016, Senti Biosciences is backed by investors that include Lux Capital, 8VC, Menlo Ventures, Intel Capital, and Matrix Partners China and is headquartered in South San Francisco.